Eastwood Bio-Medical Canada Inc. announced earnings results for the third quarter ended July 31, 2019. For the third quarter, the company announced sales was CAD 202,348 compared to CAD 161,862 a year ago. Net loss was CAD 106,231 compared to CAD 162,570 a year ago. Basic loss per share was CAD 0.01 compared to CAD 0.01 a year ago. For the nine months, sales was CAD 972,926 compared to CAD 321,162 a year ago. Net loss was CAD 389,623 compared to CAD 527,174 a year ago. Basic loss per share was CAD 0.01 compared to CAD 0.01 a year ago.